Curapath and Iris Biotech Partner to Provide Wider Access to Innovative Excipients for Drug Delivery
Curapathโs polymers are developed and manufactured at its headquarters in Valencia, Spain, and are available in both ๐ฅ&๐ ๐ฎ๐ป๐ฑ ๐๐ ๐ฃ ๐พ๐๐ฎ๐น๐ถ๐๐ These materials are designed to meet the growing demand for ๐ฏ๐ถ๐ผ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐๐ถ๐ฏ๐น๐ฒ, ๐ฏ๐ถ๐ผ๐ฑ๐ฒ๐ด๐ฟ๐ฎ๐ฑ๐ฎ๐ฏ๐น๐ฒ, ๐ฎ๐ป๐ฑ ๐ฐ๐๐๐๐ผ๐บ๐ถ๐๐ฎ๐ฏ๐น๐ฒ ๐ฒ๐ ๐ฐ๐ถ๐ฝ๐ถ๐ฒ๐ป๐๐ in modern drug delivery systems, including lipid nanoparticles (LNPs), polymeric systems, and conjugates like polymer-drug systems or antibody drug conjugates (ADCs).
Among the highlights of this partnership is the availability of ๐ฝ๐ผ๐น๐๐ผ๐ ๐ฎ๐๐ผ๐น๐ถ๐ป๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ฝ๐ผ๐น๐๐๐ฎ๐ฟ๐ฐ๐ผ๐๐ถ๐ป๐ฒ๐, versatile polymers classes offering a non-immunogenic ๐ฎ๐น๐๐ฒ๐ฟ๐ป๐ฎ๐๐ถ๐๐ฒ ๐๐ผ ๐ฃ๐๐ conferring stability, shielding and stealth functionalities to nanoformulations. These polymers provide comparable efficacy to PEGylated systems while addressing concerns related to PEG-associated immunogenicity and hypersensitivity reactions.
โ๐๐ณ๐ช๐ด ๐๐ช๐ฐ๐ต๐ฆ๐ค๐ฉโ๐ด ๐จ๐ญ๐ฐ๐ฃ๐ข๐ญ ๐ณ๐ฆ๐ข๐ค๐ฉ ๐ข๐ฏ๐ฅ ๐ญ๐ฐ๐ฏ๐จ-๐ด๐ต๐ข๐ฏ๐ฅ๐ช๐ฏ๐จ ๐ฆ๐น๐ฑ๐ฆ๐ณ๐ต๐ช๐ด๐ฆ ๐ช๐ฏ ๐ด๐ฑ๐ฆ๐ค๐ช๐ข๐ญ๐ต๐บ ๐ณ๐ฆ๐ข๐จ๐ฆ๐ฏ๐ต๐ด ๐ฎ๐ข๐ฌ๐ฆ ๐ต๐ฉ๐ฆ๐ฎ ๐ข๐ฏ ๐ช๐ฅ๐ฆ๐ข๐ญ ๐ฑ๐ข๐ณ๐ต๐ฏ๐ฆ๐ณ ๐ต๐ฐ ๐ฆ๐น๐ฑ๐ข๐ฏ๐ฅ ๐ข๐ค๐ค๐ฆ๐ด๐ด ๐ต๐ฐ ๐ฐ๐ถ๐ณ ๐ฏ๐ฆ๐น๐ต-๐จ๐ฆ๐ฏ๐ฆ๐ณ๐ข๐ต๐ช๐ฐ๐ฏ ๐ฑ๐ฐ๐ญ๐บ๐ฎ๐ฆ๐ณ๐ด,โ said Victor de la Rosa, Commercial Product Manager at Curapath. โ๐๐ฉ๐ช๐ด ๐ค๐ฐ๐ญ๐ญ๐ข๐ฃ๐ฐ๐ณ๐ข๐ต๐ช๐ฐ๐ฏ ๐ฆ๐ฎ๐ฑ๐ฐ๐ธ๐ฆ๐ณ๐ด ๐ณ๐ฆ๐ด๐ฆ๐ข๐ณ๐ค๐ฉ๐ฆ๐ณ๐ด ๐ข๐ฏ๐ฅ ๐ฅ๐ฆ๐ท๐ฆ๐ญ๐ฐ๐ฑ๐ฆ๐ณ๐ด ๐ธ๐ฐ๐ณ๐ญ๐ฅ๐ธ๐ช๐ฅ๐ฆ ๐ฃ๐บ ๐ฑ๐ณ๐ฐ๐ท๐ช๐ฅ๐ช๐ฏ๐จ ๐ด๐ต๐ณ๐ข๐ช๐จ๐ฉ๐ต๐ง๐ฐ๐ณ๐ธ๐ข๐ณ๐ฅ ๐ข๐ค๐ค๐ฆ๐ด๐ด ๐ต๐ฐ ๐ฐ๐ถ๐ณ ๐ข๐ฅ๐ท๐ข๐ฏ๐ค๐ฆ๐ฅ ๐ฎ๐ข๐ต๐ฆ๐ณ๐ช๐ข๐ญ๐ด ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ค๐ณ๐ฆ๐ข๐ต๐ช๐ฐ๐ฏ ๐ฐ๐ง ๐ด๐ข๐ง๐ฆ๐ณ, ๐ฎ๐ฐ๐ณ๐ฆ ๐ฆ๐ง๐ง๐ฆ๐ค๐ต๐ช๐ท๐ฆ ๐ต๐ฉ๐ฆ๐ณ๐ข๐ฑ๐ช๐ฆ๐ด.โ
With this partnership, Iris Biotech strengthens its portfolio of cutting-edge materials for drug delivery, offering researchers a reliable source of high-quality polymers tailored for the evolving needs of pharmaceutical innovation.
๐ฌ๐ผ๐ ๐ฐ๐ฎ๐ป ๐ณ๐ถ๐ป๐ฑ ๐๐๐ฟ๐ฎ๐ฝ๐ฎ๐๐ตโ๐ ๐ฝ๐ฟ๐ผ๐ฑ๐๐ฐ๐๐ ๐ผ๐ป ๐๐ฟ๐ถ๐ ๐๐ถ๐ผ๐๐ฒ๐ฐ๐ต ๐๐ฒ๐ฏ๐๐ถ๐๐ฒ ๐ต๐ฒ๐ฟ๐ฒ: https://iris-biotech.de/global/drug-delivery.html
๐๐ฏ๐ผ๐๐ ๐๐ฟ๐ถ๐ ๐๐ถ๐ผ๐๐ฒ๐ฐ๐ต
Iris Biotech is providing high quality products for the fields peptide and nucleic acid synthesis, linkerologyยฎ, drug delivery, and life sciences in flexible quantities from research scale to commercial production, for academia as well as industry.
Besides the broad portfolio from standard to exotic, Iris Biotech has the know-how and facilities to manufacture the compound of choice based on a Custom Synthesis.
All the services are rounded off by a strong and competent personnel customer support.
Iris Biotech is in continuous exchange with scientists all around the world to gather ideas and be ahead regarding technologies and innovations true to the slogan Empowering Peptide Innovation.
Learn more at: https://iris-biotech.de/es/home
๐๐ฏ๐ผ๐๐ ๐๐๐ฟ๐ฎ๐ฝ๐ฎ๐๐ต
Curapath is a science-driven CDMO specializing in the design, development, and GMP manufacturing of advanced drug delivery systems. We support biopharma companies from early R&D through to commercial production, enabling innovation across every stage. With a strong expertise in nanoencapsulation and non-viral gene delivery, we offer polymer and lipid-based nanoparticles tailored for a wide variety of payloads. From excipient synthesis to drug product formulation, our flexible service model and proprietary technologies ensure a seamless path to the clinic. Committed to quality, innovation, and collaboration, we help bring next-generation therapies to market faster.
Learn more at www.curapath.com
Curapath
Curapath
+34 963 76 90 80
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
